Literature DB >> 15682397

Tetraspanin-5 (Tm4sf9) mRNA expression parallels neuronal maturation in the cerebellum of normal and L7En-2 transgenic mice.

Hendrik Juenger1, C Hendrik Juenger, Martin I Holst, Katja Duffe, Jakob Jankowski, Stephan L Baader.   

Abstract

Tetraspanin-5 (Tspan-5) mRNA was recently shown to be strongly expressed within the central nervous system. In order to address Tspan-5 function during nervous system development, we performed a detailed expression analysis in the postnatal FVB/N mouse cerebellum using in situ hybridizations. Tspan-5 mRNA was expressed within cerebellar Purkinje cells (PCs) throughout postnatal development. The expression level, however, changed significantly with ongoing development. At the day of birth (P0), Tspan-5 mRNA was expressed at very low levels in PCs. At this time, PCs of the FVB/N strain are postmitotic and bear axons, but no dendrites. At P7, Tspan-5 mRNA expression was visible in all PCs, but was more prominent in those of the posterior lobules as compared to those of the anterior lobules. After P7, high levels of Tspan-5 mRNA were seen in all PCs, which is when PCs elaborate and maintain their typical dendritic tree. This demonstrates that the level of Tspan-5 mRNA is related to the developmental status of PCs. Consistently, expression of Tspan-5 mRNA was specifically reduced in PCs of L7En-2 animals, which display a delay in PC maturation during postnatal cerebellar development. In addition, whereas no Tspan-5 mRNA signal could be detected in the proliferating granule cell layer, low levels could be found in postmitotic, premigratory granule cells and high levels in settled and differentiated granule cells. Thus, the level of Tspan-5 mRNA expression correlates very well with the differentiation status of particular neurons. The level of Tspan-5 expression might therefore be important for distinct phases of neuronal maturation. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15682397     DOI: 10.1002/cne.20439

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  6 in total

1.  Expression of classical cadherins in the cerebellar anlage: quantitative and functional aspects.

Authors:  Michael Gliem; Gunnar Weisheit; Kirsten D Mertz; Elmar Endl; John Oberdick; Karl Schilling
Journal:  Mol Cell Neurosci       Date:  2006-10-16       Impact factor: 4.314

2.  Cerebral gene expression in response to single or combined gestational exposure to methylmercury and selenium through the maternal diet.

Authors:  Shalini Jayashankar; Chris N Glover; Kristin I Folven; Trond Brattelid; Christer Hogstrand; Anne-Katrine Lundebye
Journal:  Cell Biol Toxicol       Date:  2011-01-18       Impact factor: 6.691

3.  Loci Associated With Antibody Response in Feral Swine (Sus scrofa) Infected With Brucella suis.

Authors:  Courtney F Pierce; Vienna R Brown; Steven C Olsen; Paola Boggiatto; Kerri Pedersen; Ryan S Miller; Scott E Speidel; Timothy J Smyser
Journal:  Front Vet Sci       Date:  2020-11-25

4.  Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells.

Authors:  Alexander Glassmann; Sabine Molly; Lachezar Surchev; Tommy A Nazwar; Martin Holst; Wolfgang Hartmann; Stephan L Baader; John Oberdick; Torsten Pietsch; Karl Schilling
Journal:  BMC Dev Biol       Date:  2007-10-09       Impact factor: 1.978

5.  TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.

Authors:  M Gupta; D Neavin; D Liu; J Biernacka; D Hall-Flavin; W V Bobo; M A Frye; M Skime; G D Jenkins; A Batzler; K Kalari; W Matson; S S Bhasin; H Zhu; T Mushiroda; Y Nakamura; M Kubo; L Wang; R Kaddurah-Daouk; R M Weinshilboum
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

6.  Tspan5 is an independent favourable prognostic factor and suppresses tumour growth in gastric cancer.

Authors:  Peirong He; Suihai Wang; Xuefeng Zhang; Yanjun Gao; Wenbo Niu; Ningning Dong; Xiangyi Shi; Yan Geng; Qiang Ma; Ming Li; Bo Jiang; Ji-Liang Li
Journal:  Oncotarget       Date:  2016-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.